Drug
Gsk4382276a Dose Level 1
Gsk4382276a Dose Level 1: highest development phase Phase 1, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK4382276A Dose level 1 NCT05446740 | Phase 1 | Influenza, Human |
Latest
No recent events.
Follow Gsk4382276a Dose Level 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.